obesity drug news today glp-1 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 analogs, new trend in
Description
Some data suggests that higher doses of tirzepatide may be associated with a higher risk of gastrointestinal issues compared to semaglutide
H., Salem, V
Slowed Gastric Emptying: GLP-1 slows down the rate at which food leaves the stomach and enters the small intestine
Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice
doi:10.1016/j.diabet.2015.02.006 61
Hornby C, Mollan SP, Botfield H, et al
